# SJS Life Sciences — NAFDAC-Registered Products & Company Profile

SJS Life Sciences holds 22 active NAFDAC product registrations in our October 2026 copy of the Greenbook.

- Source: https://ogbogwu.com/manufacturers/sjs-life-sciences/
- NAFDAC-registered products: 22 · Antibiotics, Antimalarials, Pain & Fever
- Made in: India (22)
- Address & phone: Not on record — the NAFDAC Greenbook lists products, not offices.
- Rank by registered products: 60 of 533 manufacturers tracked (October 2026 copy)
- Nigerian company: no

## Register profile (October 2026 copy)

SJS Life Sciences has 22 products registered with NAFDAC for the Nigerian market in our October 2026 copy of the Greenbook. The full list below is compiled from that copy of the NAFDAC Greenbook — Nigeria's official register of approved products.
Its medicines are strongest in Antibiotics (8 products), Antimalarials (4 products) and Pain & Fever (2 products). Registered brands include Baltenart Tablets 80/480, Cefexiclav 325 Tablets and Erexin Tablet. Most of its products are registered as tablet, injection and powder for injection formulations. 15 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. SJS Life Sciences is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly India).

## Product categories (October 2026 copy)

- Antibiotics: 8 products
- Antimalarials: 4 products
- Pain & Fever: 2 products

## Registered products in our October 2026 copy

| Product | NAFDAC Reg. No. | Strength | Form |
|---|---|---|---|
| Algimet Suspension | A4-100611 | 6 mg/5 mL; 80 mg/5 mL; 400 mg/5 mL; 100 mg/5 mL | Suspension |
| Bactofin 500 Tablets | A4-100722 | 500 mg | Tablet |
| Baltenart 20/120 Dispersible Tablets | C4-0622 | 20 mg; 120 mg | Tablet |
| Baltenart Tablets 80/480 | C4-0699 | 80 mg; 480 mg | Tablet |
| Cefexiclav 325 Tablets | B4-6581 | 200 mg; 125 mg | Tablet |
| Cefexiclav Powder for Oral Suspension 50 mg/31.25 mg/5 mL | B4-6583 | 50 mg/5 mL; 31.25 mg/5 mL | Suspension |
| Cefexitab 200 Tablet | C4-0425 | 200 mg | Tablet |
| Debridace Ointment | B4-8268 | 521,700 IU/g; 100 mg/g | Ointment |
| Erexin Tablet | A4-100819 | 100 mg; 60 mg | Tablet |
| Falcirid Powder for Oral Suspension | B4-9358 | 80 mg; 640 mg | Powder for suspension |
| Falcirid Tablet | B4-9547 | 40 mg; 320 mg | Tablet |
| Hyorth Injection | C4-0248 | 20 mg/2 mL | Injection |
| Hyorth XL Injection | B4-7863 | 8mg; 0.16mg; 0.04mg; 8.5mg | Injection |
| Jefytran 1 g Powder for Injection (IM) | B4-7795 | 1 g | Powder for injection |
| Jefytran-SL 1.5 g Powder for Injection | B4-7955 | 1000 mg; 500 mg | Powder for injection |
| Lyfetran Powder Injection 1 g | B4-7795 | 1 g | Powder for injection |
| Narvam 300 Capsule | A4-100760 | 300 mg | Capsule |
| Nuromax 75 Capsule | A4-100723 | 75 mg | Capsule |
| Osteotide Injection | A6-0497 | 750 mcg/3 mL | Injection |
| Sjpenta Injection | C4-0021 | 30 mg | Injection |
| Supime 500 Tablet | B4-9548 | 500 mg | Tablet |
| Supime Powder for Oral Suspension 125 mg/5 mL | B4-9549 | 125 mg/5 mL | Powder for suspension |

Verify any NAFDAC number free: https://ogbogwu.com/nafdac-checker/